Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhenyuan Capsule
- Development stage
- Phase 4
- Lead developer
- Jilin Jian Yisheng Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zhenyuan Capsule is a Traditional Chinese Medicine (TCM) compound formulated as a capsule. It is being investigated for its potential to enhance immune function and for the treatment of various cardiovascular conditions, including double heart disease and coronary heart disease combined with abnormal glucose and lipid metabolism, as well as coronary heart disease with associated anxiety or depression. The specific active ingredients and their molecular mechanisms are not detailed in the provided context, but it is categorized as a health care product.
- Brand names
- Infinitus brand Zhenyuan capsule
- Other names
- 无限极牌臻源胶囊振源胶囊
02
Targets
Beyond the preview
Go deeper on Zhenyuan Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhenyuan Capsule.